Natera, Inc., a global leader in cell-free DNA testing, announced the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $55.00 per share.
Natera, Inc., a global leader in cell-free DNA testing, announced the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $55.00 per share.